首页> 外文期刊>Regenerative Biomaterials >The grafts modified by heparinization and catalytic nitric oxide generation used for vascular implantation in rats
【24h】

The grafts modified by heparinization and catalytic nitric oxide generation used for vascular implantation in rats

机译:肝素化和催化一氧化氮生成修饰的移植物用于大鼠血管植入

获取原文
       

摘要

Small-diameter (6?mm) vascular grafts are increasingly needed in peripheral vascular surgery but have few successes because of acute thrombosis, incomplete endothelialization and intimal hyperplasia after implantation. This study used electrospun poly(ε-caprolactone) as the matrix material. Heparin and selenium-containing catalyst-organoselenium modified polyethyleneimine were introduced through layer-by-layer assembly in order to build a vascular graft with in situ nitric oxide (NO) generation. The aim of this study was to explore the application of the graft with improved histocompatibility and biological function for vascular implantation in rats. After implantation in rats, compared to poly(ε-caprolactone), the modified grafts could promote the adhesion and proliferation of endothelial cells, and inhibit the adhesion of smooth muscle cells. The modified grafts remarkably promoted endothelialization, inhibited intimal hyperplasia and increased the ratio of alternatively activated macrophages (M2) to classical activated macrophages (M1). This work constructed a vascular graft with heparinization and catalytic NO generation for improving the vascularization, and accelerating the tissue regeneration by regulating the inflammatory response. The present study indicates that it is a promising method for regulating response and tissue regeneration of small diameter vascular grafts by a novel approach of combining heparinization and catalytic NO generation.
机译:小直径(<6?mm)的血管移植物在外周血管外科手术中的需求日益增加,但由于植入后的急性血栓形成,内皮化不完全和内膜增生而获得的成功很少。本研究使用电纺聚(ε-己内酯)作为基质材料。肝素和含硒催化剂-有机硒修饰的聚乙烯亚胺通过逐层组装引入,以构建具有原位一氧化氮(NO)生成的血管移植物。这项研究的目的是探索具有改善的组织相容性和生物学功能的移植物在大鼠血管植入中的应用。植入大鼠后,与聚ε-己内酯相比,修饰的移植物可促进内皮细胞的粘附和增殖,并抑制平滑肌细胞的粘附。修饰的移植物显着促进内皮化,抑制内膜增生,并增加交替激活的巨噬细胞(M2)与经典激活的巨噬细胞(M1)的比例。这项工作构建了具有肝素化和催化性NO生成的血管移植物,以改善血管生成,并通过调节炎症反应来促进组织再生。本研究表明,这是一种通过组合肝素化和催化性NO生成的新方法来调节小直径血管移植物的应答和组织再生的有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号